ArticleVaccine: X2025

Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against

Viktoria Rungelrath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.